The effect of 23-valent pneumococcal polysaccharide vaccine on immunological priming induced by 7-valent conjugate vaccine in asplenic subjects with β-thalassemia

Vaccine

Volumn 27, Issue 3, 2009, Pages 350-354

  Orthopoulos, George V ^a   Theodoridou, Maria C ^a   Ladis, Vasilis A ^b   Tsousis, Dimitris K ^b   Spoulou, Vana I ^a  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Thalassemia; Hyporesponsiveness; Pneumococcal vaccine

Indexed keywords

HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE; PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; ASPLENIA; BETA THALASSEMIA; CHILD; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; MALE; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; REPEATED DRUG DOSE; SCHOOL CHILD; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; BETA-THALASSEMIA; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN G; MALE; PNEUMOCOCCAL VACCINES; SPLENECTOMY; YOUNG ADULT;

EID: 57649224213     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.10.070     Document Type: Article

References (15)

1. Vernacchio L., Neufeld E.J., MacDonald K., Kurth S., Murakami S., Hohne C., et al. Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease. J Pediatr 133 (1998) 275-278
2. Kroon F.P., van Dissel J.T., Ravensbergen E., Nibbering P.H., and van Furth R. Enhanced antibody response to pneumococcal polysaccharide vaccine after prior immunization with conjugate pneumococcal vaccine in HIV-infected adults. Vaccine 19 (2001) 886-894
3. O'Brien K., Hochman M., and Goldblatt D. Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue?. Lancet Infect Dis 7 (2007) 597-606
4. Spoulou V.I., Tsoumas D.L., Papaevangelou V.G., Mostrou G.I., and Theodoridou M.C. Immunogenicity and immunological memory induced by a 7-valent pneumococcal CRM197 conjugate vaccine in symptomatic HIV-1 infected children. Vaccine 23 (2005) 5289-5293
5. Conception N.F., and Frasch C.E. Pneumococcal type 22F polysaccharide absorption improve the specifity of pneumococcal polysaccharide enzyme-linked immunosorbent assay. Clin Diag Lab Immunol 8 (2001) 266-272
6. Siber G.R., Chang I., Baker S., Fernsten P., O'Brien K.L., Santosham M., et al. Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies. Vaccine 25 19 (2007) 3816-3826
7. O'Brien K.L., Moulton L.H., Reid R., Weatherhotz R., Oski J., Brown L., et al. Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomized trial. Lancet 362 (2003) 366-461
8. Anttila M., Eskola J., Åhamn H., and Kaythy H. Avidity of IgG antibodies for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharides or conjugate vaccines. J Infect Dis 177 (1998) 1614-1621
9. de Roux A., Schmoele-Thoma B., Siber G.R., Hackell J.G., Kuhnke A., Ahlers N., et al. Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory. Clin Infect Dis 46 (2008) 1015-1023
10. Blum M.D., Dagan R., Mendelman P.M., Pinsk V., Giordani M., Li S., et al. A comparison of multiple regimens of pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine and pneumococcal polysaccharide vaccine in toddlers. Vaccine 18 (2000) 2359-2367
11. Bjarnarson S.P., Henneken M., Del Giudice G., and Jonsdottir I. The effect of repeated polysaccharide booster on pneumococcal conjugate induced PPS specific memory in neonatal mice (abstract P3-148). Abstracts of the 6th international symposium on pneumococci and pneumococcal diseases. Reykjavik, Iceland, 8-12 June (2008)
12. Richmond P., Kaczmarski E., Borrow R., Findlow J., Clark S., McCann R., et al. Meningococcal C polysaccharide vaccine induces immulogic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine. J Infect Dis 181 (2000) 761-764
13. Lawrence E.M., Edwards K.M., Schiffman G., Thompson J.M., Vaughn W.K., and Wright P.F. Pneumococcal vaccine in normal children. Primary and secondary vaccination. Am J Dis Child 137 (1983) 846-850
14. Jokhdar H., Borrow R., Sultan A., Adi M., Riley C., Fuller E., et al. Immunologic hyporesponsiveness to serogroup C but not serogroup A following repeated meningococcal A/C polysaccharide vaccination in Saudi Arabia. Clin Diagn Lab Immunol 11 1 (2004) 83-88
15. Breukels M.A., Zandvoort A., van Den Dobbelsteen G.P., van Den Muijsenberg A., Lodewijk M.E., Beurret M., et al. Pneumococcal conjugate vaccines overcome splenic dependency of antibody response to pneumococcal polysaccharides. Infect Immun 69 12 (2001) 7583-7587